UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease

The Journal of pediatrics, 2017-06, Vol.185, p.112-116.e1

2017

Volltextzugriff (PDF)

Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection

The Journal of infectious diseases, 2019-04, Vol.219 (9), p.1398-1406

2019

Volltextzugriff (PDF)

Clostridioides difficile infection (CDI) treatment outcomes and recurrence factor at a pediatric hospital

Antimicrobial stewardship & healthcare epidemiology : ASHE, 2022-07, Vol.2 (S1), p.s28-s28

2022

Volltextzugriff (PDF)

Risk Factors for Nonresponse to Therapy in Kawasaki Disease

The Journal of pediatrics, 2008-09, Vol.153 (3), p.365-368

2008

Volltextzugriff (PDF)

Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children's Hospital: A Contribution to a Still Inadequate Body of Evidence

Children (Basel), 2023-02, Vol.10 (2), p.350

2023

Volltextzugriff (PDF)

Clinical and Laboratory Features of Pertussis in Infants at the Onset of a California Epidemic

The Journal of pediatrics, 2011-12, Vol.159 (6), p.1044-1046

2011

Volltextzugriff (PDF)

Impact on Patient Care after Implementation of a Two-Step Process for Clostridium difficile Testing in Pediatric Hematology/Oncology

American journal of infection control, 2013-06, Vol.41 (6), p.S104-S104

2013

Volltextzugriff (PDF)

Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: A prospective, randomized, open-label, placebo-controlled pilot study

Clinical therapeutics, 2010-02, Vol.32 (2), p.265-271

2010

Volltextzugriff (PDF)

Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

The New England journal of medicine, 2015-03, Vol.372 (10), p.933-943

2015

Volltextzugriff (PDF)

1342. Serial Microbial Cell-Free DNA Next Generation Sequencing (NGS) As A Means of Diagnosis and Monitoring of Clinical Response To Treatment Of Invasive Fungal Infections (IFI) In Immunocompromised Pediatric Patients

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

Persistence of Nevirapine in Breast Milk after Discontinuation of Treatment

Clinical infectious diseases, 2007-08, Vol.45 (3), p.391-394

2007

Volltextzugriff (PDF)

Safety and Antibody Kinetics of COVID-19 Convalescent Plasma for the Treatment of Moderate to Severe Cases of SARS-CoV-2 Infection in Pediatric Patients

The Pediatric infectious disease journal, 2021-07, Vol.40 (7), p.606-611

2021

Volltextzugriff (PDF)

Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial

The Pediatric infectious disease journal, 2023-04, Vol.42 (4), p.292-298

2023

Volltextzugriff (PDF)

1675. Community Acquired Serious Bacterial Infections in Pediatric Patients Before and After COVID: Could Masks Save Lives?

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

1328. Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S674-S674

2020

Volltextzugriff (PDF)

High-grade heart block requiring transvenous pacing associated with multisystem inflammatory syndrome in children during the COVID-19 pandemic

HeartRhythm case reports, 2020-11, Vol.6 (11), p.811-814

2020

Volltextzugriff (PDF)

High risk of coronary artery aneurysms in infants younger than 6 months with Kawasaki disease

The Journal of pediatrics, 2017-04, Vol.185, p.112-116.e1

2017

Volltextzugriff (PDF)

Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial

The lancet child & adolescent health, 2021-12, Vol.5 (12), p.852-861

2021

Volltextzugriff (PDF)

Abstract O.52: Infliximab Use And Cardiac Outcome in Infants ≤ 6 Months Old: A Two Center Retrospective Study

Circulation (New York, N.Y.), 2015-04, Vol.131 (suppl_2)

2015

Volltextzugriff (PDF)

Safety and Tolerability of Clofazimine in a Cohort of Children With Odontogenic Mycobacterium abscessus Infection

Journal of the Pediatric Infectious Diseases Society, 2020-09, Vol.9 (4), p.483-485

2020

Volltextzugriff (PDF)

Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States

JAMA network open, 2022-06, Vol.5 (6), p.e2217436

2022

Volltextzugriff (PDF)

Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses

Archives of disease in childhood, 2020-08, Vol.105 (8), p.772-777

2020

Volltextzugriff (PDF)

12: The Safety and antibody kinetics of COVID-19 Convalescent Plasma for the Treatment of Moderate to Severe Cases of SARS-CoV-2 Infection in Pediatric Patients

Journal of the Pediatric Infectious Diseases Society, 2021-06, Vol.10 (Supplement_2), p.S7-S7

2021

Volltextzugriff (PDF)

A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study

The Lancet. Digital health, 2022-10, Vol.4 (10), p.e717-e726

2022

Volltextzugriff (PDF)

The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease

Contemporary clinical trials, 2019-04, Vol.79, p.98-103

2019

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(45)
Berichte
(1)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Humans
(18)
Pediatrics
(16)
Infectious Diseases
(14)
Female
(11)
Male
(11)
Child, Preschool
(9)
Biological And Medical Sciences
(8)
Infant
(8)
Medical Sciences
(8)
Child
(7)
Immunology
(7)
Infant, Newborn
(7)
Adolescent
(5)
Abstracts
(4)
Covid-19
(4)
Immunoglobulins, Intravenous - Therapeutic Use
(4)
Infants
(4)
Kawasaki Disease
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease

Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection

Clostridioides difficile infection (CDI) treatment outcomes and recurrence factor at a pediatric hospital

Risk Factors for Nonresponse to Therapy in Kawasaki Disease

Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children's Hospital: A Contribution to a Still Inadequate Body of Evidence

Clinical and Laboratory Features of Pertussis in Infants at the Onset of a California Epidemic

Impact on Patient Care after Implementation of a Two-Step Process for Clostridium difficile Testing in Pediatric Hematology/Oncology

Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: A prospective, randomized, open-label, placebo-controlled pilot study

Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

1342. Serial Microbial Cell-Free DNA Next Generation Sequencing (NGS) As A Means of Diagnosis and Monitoring of Clinical Response To Treatment Of Invasive Fungal Infections (IFI) In Immunocompromised Pediatric Patients

Persistence of Nevirapine in Breast Milk after Discontinuation of Treatment

Safety and Antibody Kinetics of COVID-19 Convalescent Plasma for the Treatment of Moderate to Severe Cases of SARS-CoV-2 Infection in Pediatric Patients

Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial

1675. Community Acquired Serious Bacterial Infections in Pediatric Patients Before and After COVID: Could Masks Save Lives?

1328. Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children

High-grade heart block requiring transvenous pacing associated with multisystem inflammatory syndrome in children during the COVID-19 pandemic

High risk of coronary artery aneurysms in infants younger than 6 months with Kawasaki disease

Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial

Abstract O.52: Infliximab Use And Cardiac Outcome in Infants ≤ 6 Months Old: A Two Center Retrospective Study

Safety and Tolerability of Clofazimine in a Cohort of Children With Odontogenic Mycobacterium abscessus Infection

Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States

Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses

12: The Safety and antibody kinetics of COVID-19 Convalescent Plasma for the Treatment of Moderate to Severe Cases of SARS-CoV-2 Infection in Pediatric Patients

A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study

The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease

Suchergebnisse filtern